Welcome to our dedicated page for Transact Tech SEC filings (Ticker: TACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransAct Technologies Inc. (NASDAQ: TACT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. TransAct files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K covering financial results, material agreements and other significant corporate events.
Recent 8-K filings describe preliminary quarterly financial results, including net sales, gross profit, operating income or loss, net income or loss, EBITDA and adjusted EBITDA, as well as FST recurring revenue and casino and gaming net sales. These filings often attach press releases as exhibits and explain the company’s use of non-GAAP measures such as EBITDA and adjusted EBITDA, including why management and lenders consider them useful in evaluating operating performance.
Other 8-Ks detail material definitive agreements, such as the Source Code Purchase and Perpetual License Agreement with Avery Dennison for BOHA™ source code and a Third Amendment to the company’s headquarters lease in Hamden, Connecticut. These documents outline key terms, payment milestones, license rights and lease modifications that can affect TransAct’s operations and cost structure.
Through Stock Titan, users can follow TransAct’s real-time filing activity as new documents are posted to EDGAR, and then use AI-powered tools to summarize and interpret lengthy reports. This includes quickly understanding the main points in 10-K and 10-Q filings, reviewing 8-K disclosures about earnings releases and agreements, and examining exhibits related to technology licensing or facilities. The filings page is a resource for investors who want to analyze TransAct’s financial reporting, risk disclosures and contractual commitments directly from its official SEC submissions.
TransAct Technologies Chief Marketing Officer Dana Loof reported an equity award of 14,124 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, vest in a single “cliff” tranche on the second anniversary of the grant, and then convert into common stock on a one-for-one basis.
TransAct Technologies reported that Chief Accounting Officer William DeFrances received a grant of 6,780 Restricted Stock Units on
The award cliff vests on the second anniversary of the grant date and then converts into common stock on a one-for-one basis, aligning the executive’s compensation with future company performance. Following these transactions, his directly held common stock balance is reported as zero shares.
TransAct Technologies Chief Technology Officer Brent Richtsmeier reported an equity compensation grant. On February 25, 2026, he acquired 14,124 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated. These RSUs vest 25% each year, starting on the first anniversary of the grant date.
Following this filing, his directly held common stock position is 21,695 shares, and his RSU holdings total 14,124 units, reflecting his long-term, equity-based compensation alignment with the company.
DILLON JOHN reported acquisition or exercise transactions in this Form 4 filing.
TRANSACT TECHNOLOGIES INC CEO John Dillon reported an equity award of 55,862 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, as Amended and Restated, and vest 25% each year starting on the first anniversary of the grant date.
Following this award, Dillon holds 55,862 Restricted Stock Units directly and 158,543 shares of common stock in direct ownership, aligning a significant portion of his compensation with the company’s future performance.
TransAct Technologies Inc Chief Revenue Officer Tracey S. Chernay received a grant of 14,124 Restricted Stock Units on February 25, 2026. The units were issued at no cash cost under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The RSUs cliff vest on the second anniversary of the grant date and then convert into common stock on a one-for-one basis. Following the grant, Chernay directly holds 14,124 RSUs and no shares of common stock are listed as directly owned after this transaction.
TransAct Technologies CEO John Dillon reported awards and vesting of performance-based equity. On February 24, 2026, he was granted 177,320 Performance Stock Units (PSUs) at no cost under the company’s 2014 Equity Incentive Plan. The PSUs were originally issued on May 1, 2025 and vest in three equal installments on February 24, 2026, 2027, and 2028.
On the same date, 59,106 PSUs were exercised and converted into 59,106 shares of common stock on a one-for-one basis, also at no cost. These PSUs were earned based on 2025 Revenue and Adjusted EBITDA performance, with a payout level of 155%. After these transactions, Dillon directly held 158,543 shares of common stock and 118,213 PSUs.
TransAct Technologies President and CFO Steven A. DeMartino reported equity award activity involving performance stock units (PSUs) and common stock. He received a grant of 62,620 PSUs at no cost and exercised 20,873 PSUs that converted into an equal number of common shares on a one-for-one basis. Following these transactions, he directly held 177,929 shares of common stock and 41,747 PSUs. A separate disposition of 7,082 common shares at
TransAct Technologies Chief Technology Officer Brent Richstmeier reported equity compensation activity tied to 2025 performance. On February 24, 2026, he received a grant of 39,215 Performance Stock Units (PSUs) that vest in three equal installments on February 24, 2026, 2027 and 2028. On the same date, 13,072 PSUs previously issued on May 1, 2025 converted into an equal number of common shares, reflecting a 155% payout based on 2025 revenue and Adjusted EBITDA results. To cover taxes related to this vesting, 3,879 common shares were disposed of at
TransAct Technologies director-affiliated entities reported an award of 14,700 restricted stock units on February 24, 2026. These RSUs were granted to director Daniel M. Friedberg under the company’s 2014 Equity Incentive Plan, cliff vest after one year, and convert into common stock on a one-for-one basis.
The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including Friedberg and Anil K. Shrivastava, who may be deemed to have a pecuniary interest. The group also reports indirect holdings of common stock through Friedberg and 325 Capital Master Fund, while disclaiming beneficial ownership except to the extent of any economic interest.
TRANSACT TECHNOLOGIES INC director Audrey Dunning received an equity grant in the form of restricted stock units. She was awarded 14,700 restricted stock units on February 24, 2026 as a grant or award. These units were issued under the company’s 2014 Equity Incentive Plan, as amended and restated.
The restricted stock units cliff vest on the first anniversary of the grant date and then convert into common stock on a one-for-one basis. After this filing, Dunning directly holds 11,475 shares of common stock, separate from the newly granted restricted stock units.